Clifford Chance advised Fresenius Kabi on the sale. German healthcare major Fresenius SE & Co. KGaA (FSNUF.PK, FSNPF.PK) announced that its operating company Fresenius Kabi transferred...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Jacobs Holding on the deal. Jacobs Holding signed an agreement to acquire ILERNA, a leading provider of official vocational education in Spain from...
You must be a Standard 1 Year member to access this content.
Clifford Chance acted for Brookfield as anchor investor. Lanza Capital (formerly known as Firmum Capital) has raised €550m for its second fund focused on car park opportunities....
You must be a Standard 1 Year member to access this content.
Clifford Chance advised healthcare group Fresenius and its Spanish subsidiary QuironSalud on the deal. Fresenius sells its 70% stake in IDCQ CRP, a co-holding entity of...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Neuraxpharm on the deal. Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announced...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders on the sale of Spanish pharmaceutical...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised China Three Gorges Spain on the deal. China Three Gorges Spain (CTGS) agreed to acquire a 619MW portfolio of photovoltaic projects in...
You must be a Standard 1 Year member to access this content.
